These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Upregulated Angiogenesis Is Incompetent to Rescue Dilated Cardiomyopathy Phenotype in Mice. Arif M; Alam P; Ahmed RP; Pandey R; Faridi HM; Sadayappan S Cells; 2021 Mar; 10(4):. PubMed ID: 33807406 [TBL] [Abstract][Full Text] [Related]
47. Effect of a myosin regulatory light chain mutation K104E on actin-myosin interactions. Duggal D; Nagwekar J; Rich R; Huang W; Midde K; Fudala R; Das H; Gryczynski I; Szczesna-Cordary D; Borejdo J Am J Physiol Heart Circ Physiol; 2015 May; 308(10):H1248-57. PubMed ID: 25770245 [TBL] [Abstract][Full Text] [Related]
52. The role of the N-terminus of the myosin essential light chain in cardiac muscle contraction. Kazmierczak K; Xu Y; Jones M; Guzman G; Hernandez OM; Kerrick WG; Szczesna-Cordary D J Mol Biol; 2009 Apr; 387(3):706-25. PubMed ID: 19361417 [TBL] [Abstract][Full Text] [Related]
53. Calponin1 inhibits dilated cardiomyopathy development in mice through the εPKC pathway. Lu D; Zhang L; Bao D; Lu Y; Zhang X; Liu N; Ge W; Gao X; Li H; Zhang L Int J Cardiol; 2014 May; 173(2):146-53. PubMed ID: 24631115 [TBL] [Abstract][Full Text] [Related]
54. Modulating the tension-time integral of the cardiac twitch prevents dilated cardiomyopathy in murine hearts. Powers JD; Kooiker KB; Mason AB; Teitgen AE; Flint GV; Tardiff JC; Schwartz SD; McCulloch AD; Regnier M; Davis J; Moussavi-Harami F JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32931484 [TBL] [Abstract][Full Text] [Related]
55. A Complete Absence of Missense Mutation in Myosin Regulatory and Essential Light Chain Genes of South Indian Hypertrophic and Dilated Cardiomyopathies. Rani DS; Nallari P; Rani J; Nizamuddin S; Seelamneni T; Narasimhan C; Thangaraj K Cardiology; 2018; 141(3):156-166. PubMed ID: 30605904 [TBL] [Abstract][Full Text] [Related]
56. Impact of familial hypertrophic cardiomyopathy-linked mutations in the NH2 terminus of the RLC on β-myosin cross-bridge mechanics. Farman GP; Muthu P; Kazmierczak K; Szczesna-Cordary D; Moore JR J Appl Physiol (1985); 2014 Dec; 117(12):1471-7. PubMed ID: 25324513 [TBL] [Abstract][Full Text] [Related]
57. Abnormal contractility in human heart myofibrils from patients with dilated cardiomyopathy due to mutations in TTN and contractile protein genes. Vikhorev PG; Smoktunowicz N; Munster AB; Copeland O; Kostin S; Montgiraud C; Messer AE; Toliat MR; Li A; Dos Remedios CG; Lal S; Blair CA; Campbell KS; Guglin M; Richter M; Knöll R; Marston SB Sci Rep; 2017 Nov; 7(1):14829. PubMed ID: 29093449 [TBL] [Abstract][Full Text] [Related]
58. Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling. Nguyen MN; Ziemann M; Kiriazis H; Su Y; Thomas Z; Lu Q; Donner DG; Zhao WB; Rafehi H; Sadoshima J; McMullen JR; El-Osta A; Du XJ Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H45-H60. PubMed ID: 30387702 [TBL] [Abstract][Full Text] [Related]
59. Investigation of a transgenic mouse model of familial dilated cardiomyopathy. Song W; Dyer E; Stuckey D; Leung MC; Memo M; Mansfield C; Ferenczi M; Liu K; Redwood C; Nowak K; Harding S; Clarke K; Wells D; Marston S J Mol Cell Cardiol; 2010 Sep; 49(3):380-9. PubMed ID: 20600154 [TBL] [Abstract][Full Text] [Related]
60. Long-Term Biased β-Arrestin Signaling Improves Cardiac Structure and Function in Dilated Cardiomyopathy. Ryba DM; Li J; Cowan CL; Russell B; Wolska BM; Solaro RJ Circulation; 2017 Mar; 135(11):1056-1070. PubMed ID: 28104714 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]